Skip to main content
FinSpry Logo
FinSpry
RMD logo
RMD
(NYSE)
ResMed Inc.
$224.09-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ResMed Inc. (RMD) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for ResMed Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
High Confidence∞:1 Buy/Sell

Average Price Target

$294.67
↑ 31.50% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest RMD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Laura Sutcliffe
Citi
Strong BuyMaintains
$330.00 → $345.00
Jonathan Block
Stifel
HoldMaintains
$260.00 → $265.00
Brandon Vazquez
William Blair
BuyReiterates
-
Anthony Petrone
Mizuho
BuyMaintains
$300.00
Adam Maeder
Piper Sandler
HoldMaintains
$270.00 → $275.00
Brett Fishbin
KeyBanc
BuyMaintains
$302.00
Nathan Treybeck
Wells Fargo
HoldMaintains
$265.00 → $270.00
David Rescott
Baird
HoldMaintains
$275.00 → $281.00
Michael Matson
Needham
HoldMaintains
-
Craig Wong-Pan
RBC Capital
BuyMaintains
$311.00 → $314.00
Lyanne Harrison
BofA Securities
BuyReiterates
$300.00

Frequently Asked Questions

What is the analyst consensus rating for RMD?

The analyst consensus rating for RMD is "Buy" based on 11 analyst recommendations.

What is the average price target for RMD?

The average 12-month price target for RMD is $294.67, representing an upside of 31.5% from the current price of $224.09.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.